To prevent flashing, restart the machine using a reduced shot size and gradually increase it back to the original shot size.

It is the responsibility of the medical device manufacturer and the person placing the medical device on the market to ensure compliance of the medical device with all applicable laws and regulations, including the suitability of all raw materials and components used for its manufacture.

Being a Great Place to Work — We listen to feedback from our associates then take action in building our high-performance culture and being a global employer of choice. Q 4 AN D FU LL Y EA R 2020 PE RF O RM AN CE $0.30 $0.52 Q4 2020 ORGANIC PERFORMANCE Sales $922 $997 +8% Operating Income EPS $58 $80 +38% +73% • Record 4th quarter sales, adjusted operating income and adjusted EPS performance • All segments delivered year-over-year sales and operating income growth, led by consumer and healthcare end markets • Clariant Masterbatch integration synergy capture ahead of schedule: $5 million realized in 2020 ($ in millions except EPS) (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition Q4 2020 SEGMENT PERFORMANCE 10 Sales Operating Income $100 $100 $100 $922 $100 $100 $100 $997 Distribution CAI SEM Total 2019 2020 $178 $272 $490 $191 $305 $526 SEM Distribution CAI +8% +7% +7% +12% $5 $5 $5 $58 $5 $5 $5 $80 Avient CAI SEM Total $17 $19 $40 $18 $30 $58 Distribution SEM CAI +38% +45% +58% +6% (3) (3) (1) (2) (1) Total company sales include intercompany sales eliminations (2) Total company reflects adjusted operating income and includes corporate costs (3) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition 2020 HIGHLIGHTS 11 • Completed transformational Clariant Masterbatch acquisition and created new brand name Avient • Increased pro forma adjusted EPS 11% from $1.74 to $1.93 as an essential supplier during the pandemic and due to growth in demand for consumer applications • Specialty Engineered Materials delivered record operating income on gains from composites • Achieved record free cash flow, increased dividend for 10th year in a row and delevered from 3.5x to 2.7x net debt to pro forma adjusted EBITDA • Culture is everything: Certified as a Great Place to Work® $133 $150 23%8% 21% 2006 2020PF Avient Portfolio Transformation 22% 59% CLARIANT MASTERBATCH: TRANSFORMATIONAL ACQUISITION 12 Clariant MB EBITDA Growth Purchase Price Multiple 10.8 9.6 6.5 2019PF 2020PF 2020PF w/ Full Synergies • Acquisition of Clariant Masterbatch significantly expands presence in healthcare, packaging and consumer end markets • Strength of portfolio – 13% EBITDA growth as an essential supplier in COVID response and recovery • Acquisition completed on 2020年7月1日 for $1.4 billion. Purchase price multiple rapidly declining on strength of business and synergy capture (1) (1) (1) (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition 13 SEM • Composites and Outdoor High Performance applications drove positive mix within SEM • Clariant Masterbatch synergy realization under way and expected to drive further margin expansion in 2021 • Portfolio transformation to high growth end markets with focus on sustainable solutions megatrend 10.1% 11.8% EBITDA MARGIN EXPANSION Distribution 6.3% 6.0% 15.2% 17.6% 11.1% 12.1% 14.5% 19.8% 13.5% 16.1% 6.4% 6.3% 15.2% 16.2% Full YearQ4 (2) (2) Total company reflects adjusted EBITDA margins SPOTLIGHT: COMPOSITES 14 • SEM delivers a record year in 2020 – 13% operating income growth and over 200 bps in margin expansion year-over-year • Prior investments in composites platform and outdoor high performance applications paying off, resulting in substantial growth over the last two years SEM Operating Income (OI % of Sales) $(0.1) $(1.0) $2.2 $19.1 $26.8 2016 2017 2018 2019 2020 Composites Performance (Operating Income) $83.7 $94.4 2019 2020 (11.2%) (13.3%) 0.1 0.1 0.2 0.5 0.6 0.7 0.8 0.9 0.9 1.0 11 12 13 14 15 16 17 18 19 20 $19 $160 $338 2011 2019 2020 0.16 0.20 0.26 0.34 0.42 0.50 0.58 0.72 0.79 0.81 0.85 11 12 13 14 15 16 17 18 19 20 21E FREE CASH FLOW AND CAPITAL ALLOCATION 15 Free Cash Flow Dividends Share Repurchases Deleveraging 3.5x 2.7x Growing Dividend Cumulative Buybacks Net Leverage $B n $ p e r sh ar e Cash Generation ~$1Bn REPURCHASED OVER LAST 10 YEARS ~$350MM PAID OVER LAST 10 YEARS ~$338MM 2.7x NET LEVERAGE (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition GREAT PLACE TO WORK!

At the Company’s 2012 Annual Meeting of Shareholders, our shareholders approved an amendment to the Original 2010 Plan to increase the number of shares authorized forff issuance under the Original 2010 Plan by 2,000,000 shares and increase certain other numerical common share limits contained in the Original 2010 Plan. These shares may be shares of original issuance or treasury shares or a combination of the two. Such shares may be shares of original issuance, treasury shares or a combination of the forff egoing.

COLOR SMART TRANSL PURPLE PURPLE 2425C

50400MSH RUSSELL PURPLE NYLON MESH 50400PEN PENNANT RUSSELL PURPLE

950RX EPIC RIO MIX ELECTRIC PURPLE Geon(TM) DB5248 PURPLE 2607 NON PHTHALATE

PURPLE 2607C TPU 2363-80A FUCHSIA PURPLE V2

PC PURPLE LIGHTER PC PURPLE DARKER

TWEEN PURPLE PE V3 STAN-TONE HCC-10980 PURPLE